Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03381755

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03381755
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03381755. Randomized; single masking; primary purpose prevention. Start 2018-01-01 (actual); primary completion 2019-12-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
Condition
Acute Coronary Syndrome
Intervention (Drug)
half-dose ticagrelor
Intervention (Drug)
standard-dose ticagrelor
Lead sponsor
First Affiliated Hospital of Harbin Medical University (class: other)

Record details

Record id
cardio:ct-nct03381755
Content hash
c51de68bc29daf93fbcd19a070ec5073e8b5beb9f6b8b5fba849d123adf82353